The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

24 Apr 2023 12:51

RNS Number : 2549X
Maven Income and Growth VCT 3 PLC
24 April 2023
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at Kintyre House, 205 West George Street, on Monday 24 April 2023 at 12 noon, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 20 April 2023, the total number of voting rights in the Company stood at and the total shares in issue were 113,495,613. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 6,491,022 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

6,293,141

173,122

13,995

10,764

6,491,022

2

To approve the Directors' Remuneration Report

6,038,582

232,128

162,013

58,299

6,491,022

3

To approve the Directors' Remuneration Policy

5,788,540

247,253

268,580

186,649

6,491,022

4

To approve a final dividend payment

6,297,123

162,876

20,097

10,926

6,491,022

5

To re-elect Atul Devani as a Director

6,111,108

228,663

75,600

75,651

6,491,022

6

To re-elect David Allan as a Director

6,145,552

225,008

56,256

64,206

6,491,022

7

To re-elect Bill Nixon as a Director

6,125,828

238,656

68,740

57,798

6,491,022

8

To re-elect Keith Pickering as a Director

6,153,750

234,550

38,516

64,206

6,491,022

9

To appoint Johnston Carmichael LLP as Auditor

6,187,937

184,091

57,605

61,389

6,491,022

10

To authorise the Directors to fix the remuneration of the Auditor

6,256,536

179,224

42,525

12,737

6,491,022

11

To authorise the Directors to allot new shares

5,688,278

180,306

531,736

90,702

6,491,022

12

To authorise disapplication of pre-emption rights

5,437,776

163,876

844,717

44,653

6,491,022

13

To authorise the Company to purchase its own shares

5,589,688

163,876

732,634

4,824

6,491,022

14

To allow a General Meeting to be called on not less than 14 days' notice

5,970,210

186,185

298,509

36,118

6,491,022

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures, along with a summary of questions submitted to the AGM and the Board's responses to them, will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2023 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

24 April 2023

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKQBQDBKDCQB
Date   Source Headline
16th Aug 20214:08 pmRNSTransaction in Own Shares
13th Aug 20212:13 pmRNSHalf-year Report
5th Aug 20214:39 pmRNSTransaction in Own Shares
3rd Aug 202111:31 amRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
16th Apr 202110:25 amRNSIssue of Equity
15th Apr 20214:30 pmRNSTransaction in Own Shares
13th Apr 20212:22 pmRNSStatement re Dividend Investment Scheme
12th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202112:28 pmRNSResult of AGM
5th Mar 20214:39 pmRNSFinal Results
29th Jan 20212:55 pmRNSTransaction in Own Shares
22nd Jan 20213:17 pmRNSNAV and Proposed Final Dividend
17th Nov 20204:29 pmRNSTransaction in Own Shares
16th Nov 20204:55 pmRNSTransaction in Own Shares
11th Nov 20204:58 pmRNSNet Asset Value(s)
28th Aug 202010:28 amRNSIssue of Equity
26th Aug 20205:23 pmRNSTransaction in Own Shares
21st Aug 20204:10 pmRNSStatement re NAV and DIS
29th Jul 20204:45 pmRNSTransaction in Own Shares
28th Jul 20204:44 pmRNSTransaction in Own Shares
24th Jul 20203:23 pmRNSHalf-year Report
9th Jul 202010:00 amRNSIssue of Equity
29th Jun 20205:25 pmRNSStatement re NAV and Interim Dividend
8th Jun 20209:33 amRNSAllotment Update
15th May 20204:55 pmRNSTransaction in Own Shares
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
8th Apr 202012:38 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update & Suspension of DIS
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
10th Mar 20204:41 pmRNSAnnual Financial Report
19th Feb 20204:09 pmRNSTransaction in Own Shares
5th Feb 202010:36 amRNSDirector/PDMR Shareholding
5th Feb 202010:32 amRNSIssue of Equity
28th Jan 202011:40 amRNSStatement re Offer for Subscription
20th Jan 20205:12 pmRNSTransaction in Own Shares
17th Jan 20204:45 pmRNSTransaction in Own Shares
17th Jan 202012:22 pmRNSNet Asset Value and Proposed Final Dividend
10th Dec 201912:28 pmRNSResult of General Meeting
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
20th Nov 20194:26 pmRNSTransaction in Own Shares
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
24th Oct 20194:06 pmRNSTransaction in Own Shares
23rd Oct 20194:43 pmRNSNet Asset Value(s)
2nd Sep 20193:34 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:26 pmRNSIssue of Equity
30th Aug 20194:27 pmRNSNet Asset Value(s)
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.